Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center

Extraosseous Ewing sarcoma is a rare entity and less is known about its clinical behavior and optimal treatment than for its counterpart in bone. This study is a retrospective analysis on a cohort of patients <21 years treated according to a “soft tissue sarcoma approach.”

[1]  S. Bielack,et al.  Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS) , 2021, Pediatric blood & cancer.

[2]  S. Ferrari,et al.  Efficacy of dose intensification in induction therapy for localized Ewing sarcoma: Italian Sarcoma Group (ISG) and Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP) ISG/AIEOP EW-1 study. , 2021 .

[3]  A. Tawil,et al.  Extraskeletal Ewing sarcoma: Diagnosis, management and prognosis. , 2021, Oncology letters.

[4]  A. Lazar,et al.  Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. , 2020, The oncologist.

[5]  H. Gelderblom,et al.  Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012). , 2020 .

[6]  U. Dirksen,et al.  High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Salah,et al.  Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol , 2019, Clinical and Translational Oncology.

[8]  P. Houghton,et al.  Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force , 2019, F1000Research.

[9]  A. Schuck,et al.  Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS‐81, ‐86, ‐91, ‐96, and ‐2002P trials , 2018, Pediatric blood & cancer.

[10]  J. Blay,et al.  High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Andrew D. Lynch,et al.  Extraskeletal versus Skeletal Ewing Sarcoma in the adult population: Controversies in care. , 2018, Surgical oncology.

[12]  M. Stevens,et al.  Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. , 2018, The Lancet. Oncology.

[13]  W. Harmsen,et al.  Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group. , 2017, International journal of radiation oncology, biology, physics.

[14]  S. Lessnick,et al.  Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group , 2015, Pediatric blood & cancer.

[15]  H. Yoshikawa,et al.  Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma. , 2016, Japanese journal of clinical oncology.

[16]  P. Houghton,et al.  The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma , 2015, Genes & cancer.

[17]  U. Dirksen,et al.  Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Donaldson,et al.  Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group , 2015, Cancer.

[19]  U. Dirksen,et al.  Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Talole,et al.  Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin , 2013, Pediatric Surgery International.

[21]  M. Eriksson,et al.  Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. , 2012 .

[22]  A. Davidoff,et al.  Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children’s Research Hospital Experience , 2012, Annals of Surgical Oncology.

[23]  H. Turna,et al.  Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome. , 2012, Japanese journal of clinical oncology.

[24]  J. Neuhaus,et al.  Clinical features and outcomes in patients with extraskeletal ewing sarcoma , 2011, Cancer.

[25]  D. Peake,et al.  Oncological outcomes of patients with Ewing's sarcoma: is there a difference between skeletal and extra-skeletal Ewing's sarcoma? , 2011, The Journal of bone and joint surgery. British volume.

[26]  U. Dirksen,et al.  Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  S. Bazarbashi,et al.  Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  Hendrik van den Berg,et al.  EXTRA-OSSEOUS EWING SARCOMA , 2009, Pediatric hematology and oncology.

[29]  T. Triche,et al.  Extraosseous Ewing's sarcoma: 25 years later. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  O. Delattre,et al.  Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  P. Terrier,et al.  Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. Ferrari,et al.  Localized unresectable non‐rhabdo soft tissue sarcomas of the extremities in pediatric age , 2005, Cancer.

[33]  S. Todo,et al.  [TNM classification--pediatric tumors]. , 1998, Gan to kagaku ryoho. Cancer & chemotherapy.

[34]  James R. Anderson,et al.  Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  E. Gehan,et al.  The intergroup rhabdomyosarcoma study‐I. A final report , 1988, Cancer.

[36]  A. Cabrera,et al.  EWING'S SARCOMA. , 1964, Surgery, gynecology & obstetrics.

[37]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[38]  M. Figari,et al.  [Extraosseous Ewing sarcoma]. , 2019, Medicina.

[39]  M. Link,et al.  Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  W. Winkelmann,et al.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.